首页 > 最新文献

Jornal Brasileiro De Pneumologia最新文献

英文 中文
Impact of telehealth during the COVID-19 pandemic on clinical and nutritional conditions of adolescents with cystic fibrosis. COVID-19 大流行期间远程保健对囊性纤维化青少年临床和营养状况的影响。
IF 2.7 4区 医学 Q2 RESPIRATORY SYSTEM Pub Date : 2024-05-27 DOI: 10.36416/1806-3756/e20230397
Lavínia Mayara da Silva Reis, Aline Antunes de Cerqueira Pinheiro, Maurício Antônio da Silva Júnior, Christine Pereira Gonçalves, Nelbe Nesi Santana
{"title":"Impact of telehealth during the COVID-19 pandemic on clinical and nutritional conditions of adolescents with cystic fibrosis.","authors":"Lavínia Mayara da Silva Reis, Aline Antunes de Cerqueira Pinheiro, Maurício Antônio da Silva Júnior, Christine Pereira Gonçalves, Nelbe Nesi Santana","doi":"10.36416/1806-3756/e20230397","DOIUrl":"10.36416/1806-3756/e20230397","url":null,"abstract":"","PeriodicalId":14845,"journal":{"name":"Jornal Brasileiro De Pneumologia","volume":"50 2","pages":"e20230397"},"PeriodicalIF":2.7,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11185150/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141160877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A critical analysis of the decreasing trends in tuberculosis cure indicators in Brazil, 2001-2022. 对 2001-2022 年巴西结核病治愈指标下降趋势的批判性分析。
IF 2.7 4区 医学 Q2 RESPIRATORY SYSTEM Pub Date : 2024-05-27 eCollection Date: 2024-01-01 DOI: 10.36416/1806-3756/e20240018
Gabriel Pavinati, Lucas Vinícius de Lima, Pedro Henrique Paiva Bernardo, Jhenicy Rubira Dias, Bárbara Reis-Santos, Gabriela Tavares Magnabosco

Objective: To analyze the temporal trend of tuberculosis cure indicators in Brazil.

Methods: An ecological time-series study using administrative data of reported cases of the disease nationwide between 2001 and 2022. We estimated cure indicators for each federative unit (FU) considering individuals with pulmonary tuberculosis, tuberculosis-HIV coinfection, and those in tuberculosis retreatment. We used regression models using joinpoint regression for trend analysis, reporting the annual percentage change and the average annual percentage change.

Results: For the three groups analyzed, we observed heterogeneity in the annual percentage change in the Brazilian FUs, with a predominance of significantly decreasing trends in the cure indicator in most FUs, especially at the end of the time series. When considering national indicators, an average annual percentage change of -0.97% (95% CI: -1.23 to -0.74) was identified for the cure of people with pulmonary tuberculosis, of -1.11% (95% CI: -1.42 to -0.85) for the cure of people with tuberculosis-HIV coinfection, and of -1.44% (95% CI: -1.62 to -1.31) for the cure of people in tuberculosis retreatment.

Conclusions: The decreasing trends of cure indicators in Brazil are concerning and underscore a warning to public authorities, as it points to the possible occurrence of other treatment outcomes, such as treatment discontinuity and death. This finding contradicts current public health care policies and requires urgent strategies aiming to promote follow-up of patients during tuberculosis treatment in Brazil.

目的:分析巴西结核病治愈指标的时间趋势:分析巴西结核病治愈指标的时间趋势:使用 2001 年至 2022 年期间全国报告病例的行政数据,进行生态时间序列研究。我们估算了每个联邦单位(FU)的治愈指标,其中包括肺结核患者、结核病-艾滋病毒合并感染者和结核病再治疗者。我们使用连接点回归模型进行趋势分析,报告年度百分比变化和平均年度百分比变化:对于所分析的三个组别,我们观察到巴西家庭单位的年度百分比变化具有异质性,大多数家庭单位的治愈指标呈显著下降趋势,尤其是在时间序列的末尾。考虑到国家指标,肺结核患者治愈率的年均百分比变化为-0.97%(95% CI:-1.23至-0.74),肺结核-艾滋病毒合并感染患者治愈率的年均百分比变化为-1.11%(95% CI:-1.42至-0.85),肺结核再治疗患者治愈率的年均百分比变化为-1.44%(95% CI:-1.62至-1.31):巴西治愈指标的下降趋势令人担忧,并向公共当局发出警告,因为这表明可能会出现其他治疗结果,如治疗中断和死亡。这一发现与当前的公共医疗保健政策相矛盾,需要制定紧急战略,以促进对巴西结核病治疗期间的患者进行随访。
{"title":"A critical analysis of the decreasing trends in tuberculosis cure indicators in Brazil, 2001-2022.","authors":"Gabriel Pavinati, Lucas Vinícius de Lima, Pedro Henrique Paiva Bernardo, Jhenicy Rubira Dias, Bárbara Reis-Santos, Gabriela Tavares Magnabosco","doi":"10.36416/1806-3756/e20240018","DOIUrl":"10.36416/1806-3756/e20240018","url":null,"abstract":"<p><strong>Objective: </strong>To analyze the temporal trend of tuberculosis cure indicators in Brazil.</p><p><strong>Methods: </strong>An ecological time-series study using administrative data of reported cases of the disease nationwide between 2001 and 2022. We estimated cure indicators for each federative unit (FU) considering individuals with pulmonary tuberculosis, tuberculosis-HIV coinfection, and those in tuberculosis retreatment. We used regression models using joinpoint regression for trend analysis, reporting the annual percentage change and the average annual percentage change.</p><p><strong>Results: </strong>For the three groups analyzed, we observed heterogeneity in the annual percentage change in the Brazilian FUs, with a predominance of significantly decreasing trends in the cure indicator in most FUs, especially at the end of the time series. When considering national indicators, an average annual percentage change of -0.97% (95% CI: -1.23 to -0.74) was identified for the cure of people with pulmonary tuberculosis, of -1.11% (95% CI: -1.42 to -0.85) for the cure of people with tuberculosis-HIV coinfection, and of -1.44% (95% CI: -1.62 to -1.31) for the cure of people in tuberculosis retreatment.</p><p><strong>Conclusions: </strong>The decreasing trends of cure indicators in Brazil are concerning and underscore a warning to public authorities, as it points to the possible occurrence of other treatment outcomes, such as treatment discontinuity and death. This finding contradicts current public health care policies and requires urgent strategies aiming to promote follow-up of patients during tuberculosis treatment in Brazil.</p>","PeriodicalId":14845,"journal":{"name":"Jornal Brasileiro De Pneumologia","volume":"50 2","pages":"e20240018"},"PeriodicalIF":2.7,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11185134/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141160783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenges in the treatment of cystic fibrosis in the era of CFTR modulatorsAuthors' replyUse of elexacaftor+tezacaftor+ivacaftor in individuals with cystic fibrosis and at least one F508del allele a systematic review and meta-analysisDiscontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY) results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trialsAssessing Safety of Discontinuing Hypertonic Saline in Those with Lower Forced Expiratory Volume in 1 Second after Elexacaftor/Tezacaftor/Ivacaftor. CFTR调节剂时代囊性纤维化治疗面临的挑战作者回复在囊性纤维化且至少有一个F508del等位基因的患者中使用eexacaftor+tezacaftor+ivacaftor的系统综述和荟萃分析在接受调节剂治疗的囊性纤维化患者中停用与继续使用高渗盐水或dornase alfa(SIMPLIFY)两项平行、多中心、开放标签、随机对照、非劣效性试验的结果评估停用高渗盐水对用力呼气容积降低者的安全性多中心、开放标签、随机对照、非劣效试验评估停用高渗盐水对 Elexacaftor/Tezacaftor/Ivacaftor 治疗后 1 秒内用力呼气容积降低者的安全性。
IF 2.9 4区 医学 Q2 RESPIRATORY SYSTEM Pub Date : 2024-05-27 DOI: 10.36416/1806-3756/e20240107
Caroline Jacoby Schmidt, Laura Silveira de Moura, Paulo de Tarso Roth Dalcin, Bruna Ziegler
{"title":"Challenges in the treatment of cystic fibrosis in the era of CFTR modulatorsAuthors' replyUse of elexacaftor+tezacaftor+ivacaftor in individuals with cystic fibrosis and at least one F508del allele a systematic review and meta-analysisDiscontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY) results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trialsAssessing Safety of Discontinuing Hypertonic Saline in Those with Lower Forced Expiratory Volume in 1 Second after Elexacaftor/Tezacaftor/Ivacaftor.","authors":"Caroline Jacoby Schmidt, Laura Silveira de Moura, Paulo de Tarso Roth Dalcin, Bruna Ziegler","doi":"10.36416/1806-3756/e20240107","DOIUrl":"10.36416/1806-3756/e20240107","url":null,"abstract":"","PeriodicalId":14845,"journal":{"name":"Jornal Brasileiro De Pneumologia","volume":"50 2","pages":"e20240107"},"PeriodicalIF":2.9,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11185157/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141160813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Feasibility of EBUS-TBNA for the molecular characterization of non-small cell lung cancer. EBUS-TBNA 用于非小细胞肺癌分子特征描述的可行性。
IF 2.7 4区 医学 Q2 RESPIRATORY SYSTEM Pub Date : 2024-05-27 DOI: 10.36416/1806-3756/e20230193
Luis Vaz Rodrigues, Marta Viegas, Rosa Cordovilla, Luis Taborda-Barata, Vitor Sousa
{"title":"Feasibility of EBUS-TBNA for the molecular characterization of non-small cell lung cancer.","authors":"Luis Vaz Rodrigues, Marta Viegas, Rosa Cordovilla, Luis Taborda-Barata, Vitor Sousa","doi":"10.36416/1806-3756/e20230193","DOIUrl":"10.36416/1806-3756/e20230193","url":null,"abstract":"","PeriodicalId":14845,"journal":{"name":"Jornal Brasileiro De Pneumologia","volume":"50 2","pages":"e20230193"},"PeriodicalIF":2.7,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11185151/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141160874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tracheobronchial amyloidosis and multiple myeloma. 气管支气管淀粉样变性和多发性骨髓瘤。
IF 2.9 4区 医学 Q2 RESPIRATORY SYSTEM Pub Date : 2024-05-27 DOI: 10.36416/1806-3756/e20240080
Luciana Volpon Soares Souza, Arthur Soares Souza, Edson Marchiori
{"title":"Tracheobronchial amyloidosis and multiple myeloma.","authors":"Luciana Volpon Soares Souza, Arthur Soares Souza, Edson Marchiori","doi":"10.36416/1806-3756/e20240080","DOIUrl":"10.36416/1806-3756/e20240080","url":null,"abstract":"","PeriodicalId":14845,"journal":{"name":"Jornal Brasileiro De Pneumologia","volume":"50 2","pages":"e20240080"},"PeriodicalIF":2.9,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11185130/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141161152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microbial variations in sputum cultures among hospitalized patients with community-acquired pneumonia: differences in sputum microbiota between asthma and COPD patients. 社区获得性肺炎住院患者痰培养物中的微生物变异:哮喘和慢性阻塞性肺病患者痰微生物群的差异。
IF 2.7 4区 医学 Q2 RESPIRATORY SYSTEM Pub Date : 2024-05-27 eCollection Date: 2024-01-01 DOI: 10.36416/1806-3756/e20230329
Fatih Uzer, Burcu Karaboğa, A Gamze Çalış, Nermin Kaplan, Rojan Barış Gedik, Ahmet Alper Durmuş, Umut Barış Inanc, Metin Akgün

Objective: To assess differences in the sputum microbiota of community-acquired pneumonia (CAP) patients with either COPD or asthma, specifically focusing on a patient population in Turkey.

Methods: This retrospective study included hospitalized patients > 18 years of age with a diagnosis of pneumonia between January of 2021 and January of 2023. Participants were recruited from two hospitals, and three patient groups were considered: CAP patients with asthma, CAP patients with COPD, and CAP patients without COPD or asthma.

Results: A total of 246 patients with CAP were included in the study, 184 (74.8%) and 62 (25.2%) being males and females, with a mean age of 66 ± 14 years. Among the participants, 52.9% had COPD, 14.2% had asthma, and 32.9% had CAP but no COPD or asthma. Upon analysis of sputum cultures, positive sputum culture growth was observed in 52.9% of patients. The most commonly isolated microorganisms were Pseudomonas aeruginosa (n = 40), Acinetobacter baumannii (n = 20), Klebsiella pneumoniae (n = 16), and Moraxella catarrhalis (n = 8). CAP patients with COPD were more likely to have a positive sputum culture (p = 0.038), a history of antibiotic use within the past three months (p = 0.03), utilization of long-term home oxygen therapy (p < 0.001), and use of noninvasive ventilation (p = 0.001) when compared with the other patient groups. Additionally, CAP patients with COPD had a higher CURB-65 score when compared with CAP patients with asthma (p = 0.004).

Conclusions: This study demonstrates that CAP patients with COPD tend to have more severe presentations, while CAP patients with asthma show varied microbial profiles, underscoring the need for patient-specific management strategies in CAP.

目的评估患有慢性阻塞性肺病或哮喘的社区获得性肺炎(CAP)患者痰微生物群的差异,特别关注土耳其的患者人群:这项回顾性研究纳入了 2021 年 1 月至 2023 年 1 月期间年龄大于 18 岁、诊断为肺炎的住院患者。参与者来自两家医院,考虑了三个患者群体:患有哮喘的 CAP 患者、患有慢性阻塞性肺病的 CAP 患者以及无慢性阻塞性肺病或哮喘的 CAP 患者:研究共纳入 246 名 CAP 患者,其中男性 184 人(占 74.8%),女性 62 人(占 25.2%),平均年龄为 66±14 岁。参与者中,52.9%患有慢性阻塞性肺病,14.2%患有哮喘,32.9%患有CAP但没有慢性阻塞性肺病或哮喘。经痰培养分析,52.9%的患者痰培养呈阳性生长。最常见的分离微生物是铜绿假单胞菌(40 例)、鲍曼不动杆菌(20 例)、肺炎克雷伯菌(16 例)和卡他氏莫拉菌(8 例)。与其他患者组相比,患有慢性阻塞性肺病的 CAP 患者更有可能出现痰培养阳性(p = 0.038)、过去三个月内有抗生素使用史(p = 0.03)、使用长期家庭氧疗(p < 0.001)和使用无创通气(p = 0.001)。此外,与哮喘 CAP 患者相比,慢性阻塞性肺疾病 CAP 患者的 CURB-65 评分更高(p = 0.004):本研究表明,患有慢性阻塞性肺病的 CAP 患者往往表现得更为严重,而患有哮喘的 CAP 患者则表现出不同的微生物特征,这突出表明有必要制定针对特定患者的 CAP 管理策略。
{"title":"Microbial variations in sputum cultures among hospitalized patients with community-acquired pneumonia: differences in sputum microbiota between asthma and COPD patients.","authors":"Fatih Uzer, Burcu Karaboğa, A Gamze Çalış, Nermin Kaplan, Rojan Barış Gedik, Ahmet Alper Durmuş, Umut Barış Inanc, Metin Akgün","doi":"10.36416/1806-3756/e20230329","DOIUrl":"10.36416/1806-3756/e20230329","url":null,"abstract":"<p><strong>Objective: </strong>To assess differences in the sputum microbiota of community-acquired pneumonia (CAP) patients with either COPD or asthma, specifically focusing on a patient population in Turkey.</p><p><strong>Methods: </strong>This retrospective study included hospitalized patients > 18 years of age with a diagnosis of pneumonia between January of 2021 and January of 2023. Participants were recruited from two hospitals, and three patient groups were considered: CAP patients with asthma, CAP patients with COPD, and CAP patients without COPD or asthma.</p><p><strong>Results: </strong>A total of 246 patients with CAP were included in the study, 184 (74.8%) and 62 (25.2%) being males and females, with a mean age of 66 ± 14 years. Among the participants, 52.9% had COPD, 14.2% had asthma, and 32.9% had CAP but no COPD or asthma. Upon analysis of sputum cultures, positive sputum culture growth was observed in 52.9% of patients. The most commonly isolated microorganisms were Pseudomonas aeruginosa (n = 40), Acinetobacter baumannii (n = 20), Klebsiella pneumoniae (n = 16), and Moraxella catarrhalis (n = 8). CAP patients with COPD were more likely to have a positive sputum culture (p = 0.038), a history of antibiotic use within the past three months (p = 0.03), utilization of long-term home oxygen therapy (p < 0.001), and use of noninvasive ventilation (p = 0.001) when compared with the other patient groups. Additionally, CAP patients with COPD had a higher CURB-65 score when compared with CAP patients with asthma (p = 0.004).</p><p><strong>Conclusions: </strong>This study demonstrates that CAP patients with COPD tend to have more severe presentations, while CAP patients with asthma show varied microbial profiles, underscoring the need for patient-specific management strategies in CAP.</p>","PeriodicalId":14845,"journal":{"name":"Jornal Brasileiro De Pneumologia","volume":"50 2","pages":"e20230329"},"PeriodicalIF":2.7,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11185154/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141161057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lung ultrasound teaching in medical education: a pilot study at a Brazilian medical school. 医学教育中的肺部超声教学:巴西一所医学院的试点研究。
IF 2.7 4区 医学 Q2 RESPIRATORY SYSTEM Pub Date : 2024-05-27 eCollection Date: 2024-01-01 DOI: 10.36416/1806-3756/e20230382
Gabrielle Turnes Pereira Demetrio, Ana Cristina Burigo Grumann, Mariângela Pimentel Pincelli, Leonardo Jonck Staub

Objective: To evaluate cognitive learning, ability to perform and interpret lung ultrasound exams, and self-perception of learning among medical students after a short pedagogical intervention at a medical school in Brazil.

Methods: An experimental pilot study was conducted with medical students at different stages of their education (basic cycle, clinical cycle, and medical internship). The participants underwent a cognitive test before and after the intervention, a practical test, a test to recognize lung ultrasound pathologies, and a qualitative evaluation test at the end of the intervention. Statistical analysis was performed using a significance level of p < 0.05.

Results: A total of 42 students were included in the study, with a median age of 23 years and a predominance of males. The mean score of the pre-intervention cognitive test was 2.97 ± 0.87, and that of the post-intervention test was 6.57 ± 1.41, showing significant improvement (p < 0.001). The score of the practical test and that of the recognition of pathologies test also showed significant improvement after the intervention. There was no significant difference in execution time between the groups. Students in the clinical cycle had a better self-perception of learning.

Conclusions: Theoretical teaching and practical training of lung ultrasound in a short pedagogical intervention can improve cognitive performance, practical skills, and interpretation of the exam. The level of learning achievement was higher among more advanced students in medical education. Additionally, the students in the clinical cycle had a better perception of their learning.

目的在巴西一所医学院进行短期教学干预后,评估医学生的认知学习、执行和解释肺部超声检查的能力以及自我学习感知:对处于不同教育阶段(基础阶段、临床阶段和医学实习阶段)的医学生进行了实验性试点研究。参与者在干预前后接受了认知测试、实践测试、肺部超声病理识别测试,并在干预结束后接受了定性评估测试。统计分析的显著性水平为 p < 0.05:共有 42 名学生参与了研究,年龄中位数为 23 岁,男性居多。干预前认知测试的平均得分为 2.97 ± 0.87,干预后测试的平均得分为 6.57 ± 1.41,有显著改善(p < 0.001)。干预后,实践测试和病理识别测试的得分也有显著提高。两组学生在执行时间上没有明显差异。结论:在短期教学干预中进行肺部超声的理论教学和实践训练可以提高认知能力、实践技能和对检查的解释能力。在医学教育中,高年级学生的学习成绩水平更高。此外,临床周期的学生对自己的学习有更好的认识。
{"title":"Lung ultrasound teaching in medical education: a pilot study at a Brazilian medical school.","authors":"Gabrielle Turnes Pereira Demetrio, Ana Cristina Burigo Grumann, Mariângela Pimentel Pincelli, Leonardo Jonck Staub","doi":"10.36416/1806-3756/e20230382","DOIUrl":"10.36416/1806-3756/e20230382","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate cognitive learning, ability to perform and interpret lung ultrasound exams, and self-perception of learning among medical students after a short pedagogical intervention at a medical school in Brazil.</p><p><strong>Methods: </strong>An experimental pilot study was conducted with medical students at different stages of their education (basic cycle, clinical cycle, and medical internship). The participants underwent a cognitive test before and after the intervention, a practical test, a test to recognize lung ultrasound pathologies, and a qualitative evaluation test at the end of the intervention. Statistical analysis was performed using a significance level of p < 0.05.</p><p><strong>Results: </strong>A total of 42 students were included in the study, with a median age of 23 years and a predominance of males. The mean score of the pre-intervention cognitive test was 2.97 ± 0.87, and that of the post-intervention test was 6.57 ± 1.41, showing significant improvement (p < 0.001). The score of the practical test and that of the recognition of pathologies test also showed significant improvement after the intervention. There was no significant difference in execution time between the groups. Students in the clinical cycle had a better self-perception of learning.</p><p><strong>Conclusions: </strong>Theoretical teaching and practical training of lung ultrasound in a short pedagogical intervention can improve cognitive performance, practical skills, and interpretation of the exam. The level of learning achievement was higher among more advanced students in medical education. Additionally, the students in the clinical cycle had a better perception of their learning.</p>","PeriodicalId":14845,"journal":{"name":"Jornal Brasileiro De Pneumologia","volume":"50 2","pages":"e20230382"},"PeriodicalIF":2.7,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11185135/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141160974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lung function and quality of life one year after severe COVID-19 in Brazil. 巴西严重 COVID-19 一年后的肺功能和生活质量。
IF 2.7 4区 医学 Q2 RESPIRATORY SYSTEM Pub Date : 2024-05-27 eCollection Date: 2024-01-01 DOI: 10.36416/1806-3756/e20230261
Tarciane Aline Prata, Arnaldo Santos Leite, Valéria Maria Augusto, Daniel Cruz Bretas, Bruno Horta Andrade, Jaqueline das Graças Ferreira Oliveira, Aline Priscila Batista, George Luiz Lins Machado-Coelho, Eliane Mancuzo, Carolina Coimbra Marinho

Objective: To evaluate symptoms, lung function, and quality of life of a cohort of patients hospitalized for severe COVID-19 12 months after hospital admission.

Methods: This was a cross-sectional study. We included severe COVID-19 survivors hospitalized in one of three tertiary referral hospitals for COVID-19 in the city of Belo Horizonte, Brazil. Participants were submitted to lung function and six-minute walk tests and completed the EQ-5D-3L questionnaire.

Results: The whole sample comprised 189 COVID-19 survivors (mean age = 59.6 ± 13.4 years) who had been admitted to a ward only (n = 96; 50.8%) or to an ICU (n = 93; 49.2%). At 12 months of follow-up, 43% of patients presented with dyspnea, 27% of whom had a restrictive ventilatory disorder and 18% of whom presented with impaired DLCO. There were no significant differences in FVC, FEV1, and TLC between the survivors with or without dyspnea. However, those who still had dyspnea had significantly more impaired DLCO (14.9% vs. 22.4%; p < 0.020) and poorer quality of life.

Conclusions: After one year, survivors of severe COVID-19 in a middle-income country still present with high symptom burden, restrictive ventilatory changes, and loss of quality of life. Ongoing follow-up is needed to characterize long COVID-19 and identify strategies to mitigate its consequences.

目的:评估重症 COVID-19 患者入院 12 个月后的症状、肺功能和生活质量:评估一组因严重 COVID-19 而住院的患者在入院 12 个月后的症状、肺功能和生活质量:这是一项横断面研究。我们纳入了在巴西贝洛奥里藏特市三家 COVID-19 三级转诊医院之一住院的重症 COVID-19 幸存者。参与者接受了肺功能和六分钟步行测试,并填写了 EQ-5D-3L 问卷:整个样本包括189名COVID-19幸存者(平均年龄为59.6 ± 13.4岁),他们只住过病房(96人,占50.8%)或住过重症监护室(93人,占49.2%)。随访12个月时,43%的患者出现呼吸困难,27%的患者出现限制性通气障碍,18%的患者出现DLCO受损。有无呼吸困难的幸存者在 FVC、FEV1 和 TLC 方面没有明显差异。然而,仍有呼吸困难的幸存者的 DLCO 受损程度明显更高(14.9% 对 22.4%;P < 0.020),生活质量也更差:结论:在一个中等收入国家,严重 COVID-19 的幸存者在一年后仍有较高的症状负担、限制性通气变化和生活质量下降。需要持续进行随访,以了解长期 COVID-19 的特征,并确定减轻其后果的策略。
{"title":"Lung function and quality of life one year after severe COVID-19 in Brazil.","authors":"Tarciane Aline Prata, Arnaldo Santos Leite, Valéria Maria Augusto, Daniel Cruz Bretas, Bruno Horta Andrade, Jaqueline das Graças Ferreira Oliveira, Aline Priscila Batista, George Luiz Lins Machado-Coelho, Eliane Mancuzo, Carolina Coimbra Marinho","doi":"10.36416/1806-3756/e20230261","DOIUrl":"10.36416/1806-3756/e20230261","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate symptoms, lung function, and quality of life of a cohort of patients hospitalized for severe COVID-19 12 months after hospital admission.</p><p><strong>Methods: </strong>This was a cross-sectional study. We included severe COVID-19 survivors hospitalized in one of three tertiary referral hospitals for COVID-19 in the city of Belo Horizonte, Brazil. Participants were submitted to lung function and six-minute walk tests and completed the EQ-5D-3L questionnaire.</p><p><strong>Results: </strong>The whole sample comprised 189 COVID-19 survivors (mean age = 59.6 ± 13.4 years) who had been admitted to a ward only (n = 96; 50.8%) or to an ICU (n = 93; 49.2%). At 12 months of follow-up, 43% of patients presented with dyspnea, 27% of whom had a restrictive ventilatory disorder and 18% of whom presented with impaired DLCO. There were no significant differences in FVC, FEV1, and TLC between the survivors with or without dyspnea. However, those who still had dyspnea had significantly more impaired DLCO (14.9% vs. 22.4%; p < 0.020) and poorer quality of life.</p><p><strong>Conclusions: </strong>After one year, survivors of severe COVID-19 in a middle-income country still present with high symptom burden, restrictive ventilatory changes, and loss of quality of life. Ongoing follow-up is needed to characterize long COVID-19 and identify strategies to mitigate its consequences.</p>","PeriodicalId":14845,"journal":{"name":"Jornal Brasileiro De Pneumologia","volume":"50 2","pages":"e20230261"},"PeriodicalIF":2.7,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11185156/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141160898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical remission after biologic therapy discontinuation in pediatric patients with severe asthma: a case series from a tertiary center. 儿科重症哮喘患者停用生物制剂治疗后的临床缓解:来自一家三级医疗中心的系列病例。
IF 2.7 4区 医学 Q2 RESPIRATORY SYSTEM Pub Date : 2024-05-27 DOI: 10.36416/1806-3756/e20230405
Giovana De Marchi Castelli, Frederico Friederich, Anasthácia Ferreira Wiemann, Giovana Dos Santos, Paulo Márcio Pitrez
{"title":"Clinical remission after biologic therapy discontinuation in pediatric patients with severe asthma: a case series from a tertiary center.","authors":"Giovana De Marchi Castelli, Frederico Friederich, Anasthácia Ferreira Wiemann, Giovana Dos Santos, Paulo Márcio Pitrez","doi":"10.36416/1806-3756/e20230405","DOIUrl":"10.36416/1806-3756/e20230405","url":null,"abstract":"","PeriodicalId":14845,"journal":{"name":"Jornal Brasileiro De Pneumologia","volume":"50 2","pages":"e20230405"},"PeriodicalIF":2.7,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11185146/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141160843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Asthma in the Brazilian Unified Health Care System: an epidemiological analysis from 2008 to 2021. 巴西统一医疗系统中的哮喘:2008 年至 2021 年流行病学分析。
IF 2.7 4区 医学 Q2 RESPIRATORY SYSTEM Pub Date : 2024-05-27 eCollection Date: 2024-01-01 DOI: 10.36416/1806-3756/e20230364
David Halen Araújo Pinheiro, João Victor Hermógenes de Souza, Alberto Fernando Oliveira Justo, Regina Maria Carvalho-Pinto, Fabiano Francisco de Lima, Celso R F Carvalho

Objective: To analyze the number of hospitalizations, the length of hospital stay, and mortality due to asthma, as well as the costs to the Unified Health Care System in Brazil between 2008 and 2021.

Methods: This was a cross-sectional epidemiological study using data from the Information Technology Department of the Brazilian Unified Health Care System. Proportional hospitalization and death rates were estimated per 100,000 population by age, microregion, and year.

Results: The number of hospitalizations and deaths due to asthma decreased from 2008 to 2021 (205,392 vs. 55,009 and 822 vs. 327, respectively). In addition, a between-sex difference was observed in asthma-related hospitalizations in 2008, and more men were hospitalized in 2021 (51.8%). Asthma mortality rates were similar for both sexes (50.0% each) in 2008, and a slight increase was observed in women's deaths in 2021 (52.9%). Even so, approximately one death/day and more than 55,000 hospitalizations were observed yearly, with a mean length of hospital stay of three days. Additionally, the Southeast region allocated more financial resources to asthma-related hospitalizations.

Conclusions: Our results showed that the number of deaths and hospitalizations due to asthma substantially declined during the study period.

摘要分析 2008 年至 2021 年期间因哮喘住院的人数、住院时间和死亡率,以及巴西统一医疗系统的成本:这是一项横断面流行病学研究,使用的数据来自巴西统一医疗系统信息技术部。按年龄、微型地区和年份估算了每 10 万人的住院率和死亡率:结果:2008 年至 2021 年,因哮喘住院和死亡的人数均有所下降(分别为 205,392 对 55,009 和 822 对 327)。此外,2008 年与哮喘相关的住院人数出现了性别差异,2021 年男性住院人数更多(51.8%)。2008 年男女哮喘死亡率相似(均为 50.0%),2021 年女性死亡率略有上升(52.9%)。尽管如此,每年仍有约 1 人/天死亡,超过 55 000 人次住院,平均住院时间为 3 天。此外,东南部地区为哮喘相关住院治疗分配了更多的财政资源:我们的研究结果表明,在研究期间,因哮喘而死亡和住院的人数大幅下降。
{"title":"Asthma in the Brazilian Unified Health Care System: an epidemiological analysis from 2008 to 2021.","authors":"David Halen Araújo Pinheiro, João Victor Hermógenes de Souza, Alberto Fernando Oliveira Justo, Regina Maria Carvalho-Pinto, Fabiano Francisco de Lima, Celso R F Carvalho","doi":"10.36416/1806-3756/e20230364","DOIUrl":"10.36416/1806-3756/e20230364","url":null,"abstract":"<p><strong>Objective: </strong>To analyze the number of hospitalizations, the length of hospital stay, and mortality due to asthma, as well as the costs to the Unified Health Care System in Brazil between 2008 and 2021.</p><p><strong>Methods: </strong>This was a cross-sectional epidemiological study using data from the Information Technology Department of the Brazilian Unified Health Care System. Proportional hospitalization and death rates were estimated per 100,000 population by age, microregion, and year.</p><p><strong>Results: </strong>The number of hospitalizations and deaths due to asthma decreased from 2008 to 2021 (205,392 vs. 55,009 and 822 vs. 327, respectively). In addition, a between-sex difference was observed in asthma-related hospitalizations in 2008, and more men were hospitalized in 2021 (51.8%). Asthma mortality rates were similar for both sexes (50.0% each) in 2008, and a slight increase was observed in women's deaths in 2021 (52.9%). Even so, approximately one death/day and more than 55,000 hospitalizations were observed yearly, with a mean length of hospital stay of three days. Additionally, the Southeast region allocated more financial resources to asthma-related hospitalizations.</p><p><strong>Conclusions: </strong>Our results showed that the number of deaths and hospitalizations due to asthma substantially declined during the study period.</p>","PeriodicalId":14845,"journal":{"name":"Jornal Brasileiro De Pneumologia","volume":"50 2","pages":"e20230364"},"PeriodicalIF":2.7,"publicationDate":"2024-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11185155/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141160799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Jornal Brasileiro De Pneumologia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1